Skip to main content

Table 1 Basic information on CMR patients: control subjects versus HCM; without adverse clinical events versus with combined outcome

From: Predictive value of left atrial strain analysis in adverse clinical events in patients with hypertrophic cardiomyopathy: a CMR study

Parameters

Control subjects (n = 89)

HCM population (n = 99)

p value

HCM patient without adverse clinical events (n = 81)

HCM patient with adverse clinical events (n = 18)

p value

Baseline and clinical

      

Age at CMR scan, years

52.74 ± 10.03

55 (46, 65)

0.200

51.85 ± 13.13

67 (62, 69)

< 0.001***

Men, n, %

67, 75.28%

71, 71.7%

0.581

61, 75.3%

10, 55.6%

0.092

Family history, n, %

31, 31.3%

50, 61.7%

12, 66.7%

0.695

Body mass index, kg/m2

26.40 (24.51, 28.40)

26.40 ± 3.39

0.821

26.65 ± 3.36

25.28 ± 3.35

0.121

Heart rate, beat/min

68 (64, 75)

66 (58, 68)

 < 0.001***

67 (59, 71)

60.17 ± 7.52

0.026*

Hypertension, n, %

25, 28.1%

62, 62.6%

 < 0.001***

50, 61.7%

12, 66.7%

0.695

Systolic blood pressure, mmHg

150 (125, 180)

150 (123, 180)

159.17 ± 36.81

0.413

Diastolic blood pressure, mmHg

90 (77, 110)

90 (77, 110)

98.28 ± 26.47

0.420

Diabetes mellitus, n, %

15, 16.9%

17, 17.2%

0.954

14, 17.3%

3, 16.7%

1.000

Smoking history, n, %

44, 49.4%

36, 36.4%

0.070

29, 35.8%

7, 38.9%

0.806

CAD, n, %

26, 26.3%

22, 27.2%

4, 22.2%

0.721

PE, n, %

0, 0%

0, 0%

0, 0%

CKD, n, %

1, 1.01%

1, 1.23%

0, 0%

  1. Data were expressed as number (percentage), mean ± standard deviation, or median (interquartile range)
  2. CAD, Coronary atherosclerotic heart disease; PE, Pulmonary embolism; CKD, Chronic Kidney Disease
  3. “*”, “**”, and “***” reflect that the difference between groups is statistically significant
  4. “*” represents p < 0.05; “**” represents p < 0.01; “***” represents p < 0.001